{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:42:36Z","timestamp":1791225756689,"version":"4.1.0"},"reference-count":115,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:00:00Z","timestamp":1763251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is the second most common neurodegenerative disease worldwide. It is characterized by the accumulation of \u03b1-synuclein, and its symptoms arise from the loss of dopaminergic neurons in the substantia nigra, contributing to the development of both motor (MS) and non-motor (NMS) symptoms. The detailed pathomechanism of the disease progression is unknown, although microglia activation and ongoing neuroinflammation are thought to play key roles. It is known that adipokines have a wide-ranging impact on various processes, including those implicated in PD. We have analyzed a series of studies regarding the significance and involvement of leptin, adiponectin, resistin, visfatin, and progranulin in neurodegeneration. Available evidence suggests that adipokines modulate PD pathology through their effects on inflammation, oxidative stress, or \u03b1-synuclein accumulation. Thus, the examined adipokines may serve as potential targets for PD treatment or as biomarkers of disease progression.<\/jats:p>","DOI":"10.3390\/molecules30224431","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:33:04Z","timestamp":1763469184000},"page":"4431","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Summarizing the Role of Selected Adipokines in Parkinson\u2019s Disease: What Is Known About Leptin, Adiponectin, Resistin, Visfatin, and Progranulin in Neurodegeneration?"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6370-8299","authenticated-orcid":false,"given":"Jan","family":"Milanowski","sequence":"first","affiliation":[{"name":"Students Research Club of Medical Biology, Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 24 Kar\u0142owicza St., 85-092 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1640-9196","authenticated-orcid":false,"given":"Marta","family":"Paw\u0142owska","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 24 Kar\u0142owicza St., 85-092 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4492-4796","authenticated-orcid":false,"given":"Alina","family":"Wo\u017aniak","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 24 Kar\u0142owicza St., 85-092 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8123-3882","authenticated-orcid":false,"given":"Karolina","family":"Szewczyk-Golec","sequence":"additional","affiliation":[{"name":"Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toru\u0144, 24 Kar\u0142owicza St., 85-092 Bydgoszcz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/00207454.2018.1486837","article-title":"Awareness and current knowledge of Parkinson\u2019s disease: A neurodegenerative disorder","volume":"129","author":"Khan","year":"2018","journal-title":"Int. J. Neurosci."},{"key":"ref_2","first-page":"501","article-title":"Parkinson\u2019s Disease in Women and Men: What\u2019s the Difference?","volume":"9","author":"Cerri","year":"2019","journal-title":"J. Park. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019 s Disease Diagnosis of PD","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_4","first-page":"S29","article-title":"Young Onset Parkinson\u2019s Disease: A Modern and Tailored Approach","volume":"10","author":"Post","year":"2020","journal-title":"J. Park. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3109\/00207454.2014.961454","article-title":"Cerebrospinal Fluid Alpha-Synuclein as a Biomarker for Parkinson\u2019s Disease Diagnosis: A Systematic Review and Meta-Analysis","volume":"125","author":"Gao","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gao, C., Jiang, J., Tan, Y., and Chen, S. (2023). Microglia in Neurodegenerative Diseases: Mechanism and Potential Therapeutic Targets, Springer.","DOI":"10.1038\/s41392-023-01588-0"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.immuni.2019.12.003","article-title":"Microglia, Lifestyle Stress, and Neurodegeneration","volume":"52","author":"Madore","year":"2020","journal-title":"Immunity"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e13031","DOI":"10.1111\/acel.13031","article-title":"Oxidative Stress in the Aging Substantia Nigra and the Etiology of Parkinson\u2019s Disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"De Challenges in the Diagnosis of Parkinson\u2019s Disease","volume":"20","author":"Tolosa","year":"2022","journal-title":"Lancet Neurol."},{"key":"ref_10","unstructured":"Deeb, W., Nozile-Firth, K., and Okun, M.S. (2019). Parkinson\u2019s Disease: Diagnosis and Appreciation of Comorbidities, Elsevier. [1st ed.]."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41531-018-0041-9","article-title":"Optimizing Parkinson \u2019 s Disease Diagnosis: The Role of a Dual Nuclear Imaging Algorithm","volume":"4","author":"Langston","year":"2018","journal-title":"npj Park. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s Disease: Etiopathogenesis and Treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/jnc.12751","article-title":"Dyskinesia in Parkinson\u2019s Disease: Mechanisms and Current Non-Pharmacological Interventions","volume":"130","author":"Heumann","year":"2014","journal-title":"J. Neurochem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s12264-017-0183-5","article-title":"Biomarkers for Parkinson\u2019s Disease: Recent Advancement","volume":"33","author":"Lotankar","year":"2017","journal-title":"Neurosci. Bull."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Milanowski, J., Kozerawski, K., Fal\u0119cka, W., Dudek, D., Lisewska, B., Lisewski, P., Nuszkiewicz, J., Weso\u0142owski, R., Wojtasik, J., and Mila-Kierzenkowska, C. (2023). Changes in the Secretion of Melatonin and Selected Adipokines during the Progression of Parkinson\u2019s Disease\u2014Preliminary Studies. Metabolites, 13.","DOI":"10.3390\/metabo13050668"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Milanowski, J., Nuszkiewicz, J., Lisewska, B., Lisewski, P., and Szewczyk-Golec, K. (2024). Adipokines, Vitamin D, and Selected Inflammatory Biomarkers among Parkinson\u2019s Disease Patients with and without Dyskinesia: A Preliminary Examination. Metabolites, 14.","DOI":"10.3390\/metabo14020106"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sudan, S.K., Deshmukh, S.K., Poosarla, T., Holliday, N.P., Dyess, D.L., Singh, A.P., and Singh, S. (2020). Resistin: An inflammatory cytokine with multi-faceted roles in cancer. Biochim. Biophys. Acta Rev. Cancer, 1874.","DOI":"10.1016\/j.bbcan.2020.188419"},{"key":"ref_18","first-page":"71","article-title":"Serum Leptin Levels in Iranian Patients with Parkinson\u2019s Disease","volume":"17","author":"Salari","year":"2018","journal-title":"Iran. J. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cyto.2016.10.011","article-title":"Leptin in inflammation and autoimmunity","volume":"98","year":"2017","journal-title":"Cytokine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"104692","DOI":"10.1016\/j.neuint.2020.104692","article-title":"Leptin Mediates Protection of Hydrogen Sulfide against 6-Hydroxydopamine-Induced Parkinson\u2019s Disease: Involving Enhancement in Warburg Effect","volume":"135","author":"Yang","year":"2020","journal-title":"Neurochem. Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clnu.2012.07.004","article-title":"The Sleeve Gastrectomy Intervention to Treat Morbid Obesity in a Parkinson\u2019s Disease Patient","volume":"32","author":"Barichella","year":"2013","journal-title":"Clin. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Obradovic, M., Sudar-Milovanovic, E., Soskic, S., Essack, M., Arya, S., Stewart, A.J., Gojobori, T., and Isenovic, E.R. (2021). Leptin and Obesity: Role and Clinical Implication. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.585887"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0404.2009.01185.x","article-title":"Leptin and Ghrelin Concentrations and Weight Loss in Parkinson\u2019s Disease","volume":"121","author":"Fiszer","year":"2010","journal-title":"Acta Neurol. Scand."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4103\/0028-3886.266268","article-title":"Deep Brain Stimulation in Parkinson\u2019s Disease","volume":"67","author":"Malek","year":"2019","journal-title":"Neurol. India"},{"key":"ref_25","first-page":"235","article-title":"Subthalamic Nucleus Deep Brain Stimulation in Parkinson\u2019s Disease: The Effect of Varying Stimulation Parameters","volume":"7","author":"Dayal","year":"2017","journal-title":"J. Park. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41582-018-0128-2","article-title":"Deep brain stimulation: Current challenges and future directions","volume":"15","author":"Lozano","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000335045","article-title":"The Role of Ghrelin, Neuropeptide y and Leptin Peptides in Weight Gain after Deep Brain Stimulation for Parkinson\u2019s Disease","volume":"90","author":"Markaki","year":"2012","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"ref_28","first-page":"437","article-title":"Hormonal Regulators of Food Intake and Weight Gain in Parkinson\u2019s Disease after Subthalamic Nucleus Stimulation","volume":"32","author":"Jech","year":"2011","journal-title":"Neuroendocrinol. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1600-0404.2010.01469.x","article-title":"Change of the Melanocortin System Caused by Bilateral Subthalamic Nucleus Stimulation in Parkinson\u2019s Disease","volume":"124","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Carrillo, F., Palomba, N.P., Ghirimoldi, M., Did\u00f2, C., Fortunato, G., Khoso, S., Giloni, T., Santilli, M., Bocci, T., and Priori, A. (2024). Multiomics Approach Discloses Lipids and Metabolites Profiles Associated to Parkinson\u2019s Disease Stages and Applied Therapies. Neurobiol. Dis., 202.","DOI":"10.1016\/j.nbd.2024.106698"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mds.22466","article-title":"Weight Loss, Body Fat Mass, and Leptin in Parkinson\u2019s Disease","volume":"24","author":"Toss","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2014.01.021","article-title":"Circulating Levels of Adipokines in Parkinson\u2019s Disease","volume":"339","author":"Rocha","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_33","first-page":"241","article-title":"Parkinson Hastalar\u0131nda Bili\u015fsel Durum ve Serum Leptin D\u00fczeyleri","volume":"53","author":"Kenangil","year":"2016","journal-title":"Noropsikiyatri Ars."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.parkreldis.2016.09.016","article-title":"Body Fat Distribution in Parkinson\u2019s Disease: An MRI-Based Body Fat Quantification Study","volume":"33","author":"Bernhardt","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/mds.1165","article-title":"Serum Leptin Concentrations and Satiety in Parkinson\u2019s Disease Patients with and without Weight Loss","volume":"16","author":"Evidente","year":"2001","journal-title":"Mov. Disord."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Reda, E., Hassaneen, S., and El-Abhar, H.S. (2018). Novel Trajectories of Bromocriptine Antidiabetic Action: Leptin-IL-6\/JAK2\/p-STAT3\/SOCS3, p-IR\/p-AKT\/GLUT4, PPAR-\u03b3\/Adiponectin, Nrf2\/PARP-1, and GLP-1. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.00771"},{"key":"ref_37","first-page":"576020","article-title":"Serum Leptin Concentrations in Turkish Parkinson\u2019s Disease Population","volume":"2014","author":"Ozdilek","year":"2014","journal-title":"Parkinsons. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/mds.26678","article-title":"Association of Leptin with Orthostatic Blood Pressure Changes in Parkinson\u2019s Disease","volume":"31","author":"Nakamura","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_39","first-page":"627","article-title":"6-Hydroxydopamine-Induced Model of Parkinson\u2019s Disease","volume":"Volume 11","author":"Andrzejewski","year":"2020","journal-title":"Genetics, Neurology, Behavior, and Diet in Parkinson\u2019s Disease, Volume 2"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Bartl, M., Dakna, M., Galasko, D., Hutten, S.J., Foroud, T., Quan, M., Marek, K., Siderowf, A., Franz, J., and Trenkwalder, C. (2021). Biomarkers of Neurodegeneration and Glial Activation Validated in Alzheimer\u2019s Disease Assessed in Longitudinal Cerebrospinal Fluid Samples of Parkinson\u2019s Disease. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0257372"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"34479","DOI":"10.1074\/jbc.M705426200","article-title":"Leptin Protects against 6-Hydroxydopamine-Induced Dopaminergic Cell Death via Mitogen-Activated Protein Kinase Signaling","volume":"282","author":"Weng","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/1440-1681.13587","article-title":"Hydrogen Sulphide Attenuates Neuronal Apoptosis of Substantia Nigra by Re-Establishing Autophagic Flux via Promoting Leptin Signalling in a 6-Hydroxydopamine Rat Model of Parkinson\u2019s Disease","volume":"49","author":"Jiang","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12974-022-02399-w","article-title":"Neurodegeneration in the Centrally-Projecting Edinger\u2013Westphal Nucleus Contributes to the Non-Motor Symptoms of Parkinson\u2019s Disease in the Rat","volume":"19","author":"Pytel","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and Pathogenesis of Parkinson\u2019s Syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.cell.2020.08.004","article-title":"The In Situ Structure of Parkinson\u2019s Disease-Linked LRRK2","volume":"17","author":"Watanabe","year":"2020","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/2211-5463.13717","article-title":"LRRK2 Negatively Regulates Glucose Tolerance via Regulation of Membrane Translocation of GLUT4 in Adipocytes","volume":"13","author":"Kawakami","year":"2023","journal-title":"FEBS Open Bio"},{"key":"ref_47","first-page":"119","article-title":"Metabolic Abnormalities and Hypoleptinemia in \u03b1-Synuclein A53T Mutant Mice","volume":"1","author":"Rothman","year":"2014","journal-title":"Comput. Model. Eng. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s12640-009-9109-y","article-title":"Mitochondrial Uncoupling Protein-2 (UCP2) Mediates Leptin Protection against MPP+ Toxicity in Neuronal Cells","volume":"17","author":"Ho","year":"2010","journal-title":"Neurotox. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.14341\/probl12827","article-title":"Adiponectin: A Pleiotropic Hormone With Multifaceted Roles","volume":"67","author":"Shklyaev","year":"2021","journal-title":"Probl. Endokrinol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Choi, H.M., Doss, H.M., and Kim, K.S. (2020). Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041219"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13075-018-1736-3","article-title":"Potential Therapeutic Antibodies Targeting Specific Adiponectin Isoforms in Rheumatoid Arthritis","volume":"20","author":"Lee","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Achari, A.E., and Jain, S.K. (2017). Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061321"},{"key":"ref_53","unstructured":"van Andel, M., Heijboer, A.C., and Drent, M.L. (2018). Adiponectin and Its Isoforms in Pathophysiology, Elsevier. [1st ed.]."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/acn3.77","article-title":"Disease Modifying Effect of Adiponectin in Model of \u03b1-Synucleinopathies","volume":"1","author":"Sekiyama","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Root, J., Mendsaikhan, A., Nandy, S., Taylor, G., Wang, M., Araujo, L.T., Merino, P., Ryu, D., Holler, C., and Thompson, B.M. (2023). Granulins Rescue Inflammation, Lysosome Dysfunction, and Neuropathology in a Mouse Model of Progranulin Deficiency. bioRxiv Prepr. Serv. Biol., 43.","DOI":"10.1101\/2023.04.17.536004"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Rizzo, M.R., Fasano, R., and Paolisso, G. (2020). Adiponectin and Cognitive Decline. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062010"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Khoramipour, K., Chamari, K., Hekmatikar, A.A., Ziyaiyan, A., Taherkhani, S., Elguindy, N.M., and Bragazzi, N.L. (2021). Diseases, and Effects of Nutrition. Nutrients, 13.","DOI":"10.3390\/nu13041180"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/j.2040-4603.2018.tb00036.x","article-title":"Adiponectin Regulation and Function","volume":"8","author":"Fang","year":"2018","journal-title":"Compr. Physiol."},{"key":"ref_59","first-page":"624764","article-title":"Serum Adiponectin Levels in Advanced-Stage Parkinson\u2019s Disease Patients","volume":"2011","author":"Cassani","year":"2011","journal-title":"Park. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbrc.2006.02.186","article-title":"Adiponectin Protects Human Neuroblastoma SH-SY5Y Cells against MPP +-Induced Cytotoxicity","volume":"343","author":"Jung","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCRESAHA.120.314458","article-title":"Adiponectin, leptin and cardiovascular disorders","volume":"128","author":"Zhao","year":"2021","journal-title":"Circ. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11255-021-02828-4","article-title":"Mutual Effect Modification between Adiponectin and HDL as Risk Factors of Cardiovascular Events in Type 2 Diabetes Individuals: A Cohort Study","volume":"53","author":"Roumeliotis","year":"2021","journal-title":"Int. Urol. Nephrol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"153953","DOI":"10.1016\/j.metabol.2019.153953","article-title":"The Role of Adiponectin in Cholesterol Efflux and HDL Biogenesis and Metabolism","volume":"100","author":"Hafiane","year":"2019","journal-title":"Metabolism"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Miao, W., Jiang, L., Xu, F., Lyu, J., Jiang, X., He, M., Liu, Y., Yang, T., Leak, R.K., and Stetler, R.A. (2021). Adiponectin Ameliorates Hypoperfusive Cognitive Deficits by Boosting a Neuroprotective Microglial Response. Prog. Neurobiol., 205.","DOI":"10.1016\/j.pneurobio.2021.102125"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/jop.2018.0152","article-title":"The Neuroprotective Effect of the Adiponectin Receptor Agonist AdipoRon on Glutamate-Induced Cell Death in Rat Primary Retinal Ganglion Cells","volume":"35","author":"Uchida","year":"2019","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Zhang, S., Wu, X., Wang, J., Shi, Y., Hu, Q., Cui, W., Bai, H., Zhou, J., Du, Y., and Han, L. (2022). Adiponectin\/AdiopR1 Signaling Prevents Mitochondrial Dysfunction and Oxidative Injury after Traumatic Brain Injury in a SIRT3 Dependent Manner. Redox Biol., 54.","DOI":"10.1016\/j.redox.2022.102390"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Ng, R.C.L., and Chan, K.H. (2017). Potential Neuroprotective Effects of Adiponectin in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18030592"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Skou, L.D., Johansen, S.K., Okarmus, J., and Meyer, M. (2024). Pathogenesis of DJ-1\/PARK7-Mediated Parkinson\u2019s Disease. Cells, 13.","DOI":"10.3390\/cells13040296"},{"key":"ref_69","first-page":"45","article-title":"Mitochondria and Parkinson\u2019s Disease: Clinical, Molecular, and Translational Aspects","volume":"11","author":"Borsche","year":"2021","journal-title":"J. Park. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12974-023-02776-z","article-title":"PARK7\/DJ-1 in Microglia: Implications in Parkinson\u2019s Disease and Relevance as a Therapeutic Target","volume":"20","author":"Scafidi","year":"2023","journal-title":"J. Neuroinflamm."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/00207454.2013.846340","article-title":"Adiponectin Offers Protection against L166P Mutant DJ-1-Induced Neuronal Cytotoxicity Mediated by APPL1-Dependent AMPK Activation","volume":"124","author":"Li","year":"2014","journal-title":"Int. J. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10863-019-09798-4","article-title":"Role of DJ-1 in the Mechanism of Pathogenesis of Parkinson\u2019s Disease","volume":"51","author":"Dolgacheva","year":"2019","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/acn3.51480","article-title":"LINC00667 Regulates MPP+-Induced Neuronal Injury in Parkinson\u2019s Disease","volume":"9","author":"Huo","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"7769355","DOI":"10.1155\/2022\/7769355","article-title":"Quercetin Protects against MPP+\/MPTP-Induced Dopaminergic Neuron Death in Parkinson\u2019s Disease by Inhibiting Ferroptosis","volume":"2022","author":"Lin","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"110180","DOI":"10.1016\/j.neuropharm.2024.110180","article-title":"Intranasal AdipoRon Mitigates Motor and Cognitive Deficits in Hemiparkinsonian Rats through Neuroprotective Mechanisms against Oxidative Stress and Synaptic Dysfunction","volume":"262","author":"Alimohammadi","year":"2025","journal-title":"Neuropharmacology"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Park, J.S., Choe, K., Lee, H.J., Park, T.J., and Kim, M.O. (2023). Neuroprotective Effects of Osmotin in Parkinson\u2019s Disease-Associated Pathology via the AdipoR1\/MAPK\/AMPK\/MTOR Signaling Pathways. J. Biomed. Sci., 30.","DOI":"10.1186\/s12929-023-00961-z"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10072-019-04216-4","article-title":"Serum Adiponectin Levels between Patients with Parkinson\u2019s Disease and Those with PSP","volume":"41","author":"Kataoka","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1111\/febs.15322","article-title":"Resistin in Metabolism, Inflammation, and Disease","volume":"287","author":"Tripathi","year":"2020","journal-title":"FEBS J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mad.2019.01.004","article-title":"Resistin: A Reappraisal","volume":"178","author":"Acquarone","year":"2019","journal-title":"Mech. Ageing Dev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cardiores.2005.09.015","article-title":"Resistin Is Secreted from Macrophages in Atheromas and Promotes Atherosclerosis","volume":"69","author":"Jung","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"111341","DOI":"10.1016\/j.mce.2021.111341","article-title":"Is Resistin the Master Link between Inflammation and Inflammation-Related Chronic Diseases?","volume":"533","author":"Taouis","year":"2021","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/mds.23500","article-title":"Myoclonus and Angiokeratomas in Adult Galactosialidosis","volume":"26","author":"Mri","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s11064-019-02726-3","article-title":"Resistin-Inhibited Neural Stem Cell-Derived Astrocyte Differentiation Contributes to Permeability Destruction of the Blood\u2013Brain Barrier","volume":"44","author":"Liu","year":"2019","journal-title":"Neurochem. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jcp.24163","article-title":"Resistin Protects against 6-Hydroxydopamine-Induced Cell Death in Dopaminergic-like MES23.5 Cells","volume":"228","author":"Lu","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-0716-2213-1_2","article-title":"Mitochondrial Membrane Potential Assay","volume":"2474","author":"Sakamuru","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.phrs.2018.06.022","article-title":"NAMPT: A Pleiotropic Modulator of Monocytes and Macrophages","volume":"135","author":"Travelli","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/dom.12171","article-title":"The importance of NAMPT\/NAD\/SIRT1 in the systemic regulation of metabolism and ageing","volume":"3","author":"Imai","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrendo.2015.117","article-title":"Physiological and Pathophysiological Roles of NAMPT and NAD Metabolism","volume":"11","author":"Garten","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Dakroub, A., Nasser, S.A., Younis, N., Bhagani, H., Al-dhaheri, Y., Pintus, G., Eid, A.A., El-yazbi, A.F., and Eid, A.H. (2020). Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders. Cells, 9.","DOI":"10.3390\/cells9112444"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Geyer, M. (2011). Novel Antischizophrenia Treatments. Handbook of Experimental Pharmacology, Springer.","DOI":"10.1007\/978-3-642-25758-2"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.1002\/jcp.30345","article-title":"Visfatin: An Emerging Adipocytokine Bridging the Gap in the Evolution of Cardiovascular Diseases","volume":"236","author":"Dakroub","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"ref_92","first-page":"202","article-title":"Analysis of circulating metabolites to differentiate Parkinson\u2019s disease and essential tremor","volume":"19","author":"Ostrakhovitch","year":"2022","journal-title":"Neurosci. Lett."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/hmg\/ddac077","article-title":"Alpha-Synucleinopathy Reduces NMNAT3 Protein Levels and Neurite Formation That Can Be Rescued by Targeting the NAD+ Pathway","volume":"31","author":"Parsons","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Santiago, J.A., Bottero, V., and Potashkin, J.A. (2018). Evaluation of RNA Blood Biomarkers in the Parkinson\u2019s Disease Biomarkers Program. Front. Aging Neurosci., 10.","DOI":"10.3389\/fnagi.2018.00157"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2174\/1871523018666190724124214","article-title":"Progranulin Regulates Inflammation and Tumor","volume":"19","author":"Liu","year":"2019","journal-title":"Antiinflamm. Antiallergy Agents Med. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/14728222.2018.1487951","article-title":"Progranulin as a Therapeutic Target for Dementia","volume":"22","author":"Galimberti","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Horinokita, I., Hayashi, H., Oteki, R., Mizumura, R., Yamaguchi, T., Usui, A., Yuan, B., and Takagi, N. (2019). Involvement of Progranulin and Granulin Expression in Inflammatory Responses after Cerebral Ischemia. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20205210"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13024-021-00472-1","article-title":"Processing of progranulin into granulins involves multiple lysosomal proteases and is affected in frontotemporal lobar degeneration","volume":"3","author":"Mohan","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.tcb.2022.09.006","article-title":"Lysosomal Functions of Progranulin and Implications for Treatment of Frontotemporal Dementia","volume":"33","author":"Simon","year":"2023","journal-title":"Trends Cell Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-017-0205-9","article-title":"Lysosomal Processing of Progranulin","volume":"12","author":"Zhou","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1468-1331.2009.02621.x","article-title":"GRN 3 \u00a2 UTR + 78 C > T Is Not Associated with Risk for Parkinson \u00d5 s Disease","volume":"16","author":"Wider","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1212\/01.wnl.0000327563.10320.2b","article-title":"Progranulin Variability Has No Major Role in Parkinson Disease Genetic Etiology","volume":"71","author":"Nuytemans","year":"2008","journal-title":"Neurology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neurobiolaging.2018.03.007","article-title":"Neurobiology of Aging Clinical Variability and Onset Age Modi Fi Ers in an Extended Belgian GRN Founder Family","volume":"67","author":"Wauters","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/archneur.64.10.1436","article-title":"Brouwers Alzheimer and Parkinson Diagnoses in Progranulin Null Mutation Carriers in an Extended Founder Family","volume":"64","author":"Brouwers","year":"2015","journal-title":"Arch. Neurol."},{"key":"ref_105","first-page":"5","article-title":"Association between GRN Rs5848 Polymorphism and Parkinson 9 s Disease in Taiwanese Population","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3109\/00207454.2015.1086345","article-title":"Association Analysis of the GRN Rs5848 and MAPT Rs242557 Polymorphisms in Parkinson\u2019s Disease and Multiple System Atrophy: A Large-Scale Population-Based Study and Meta-Analysis","volume":"126","author":"Chen","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2020.09.019","article-title":"Parkinsonism and Related Disorders Isolated Parkinsonism Is an Atypical Presentation of GRN and C9orf72 Gene Mutations","volume":"80","author":"Saracino","year":"2020","journal-title":"Park. Relat. Disord."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2008.03.004","article-title":"Deletion of the Progranulin Gene in Patients with Frontotemporal Lobar Degeneration or Parkinson Disease","volume":"31","author":"Deramecourt","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/glia.22663","article-title":"Changes in Matrix Metalloprotease Activity and Progranulin Levels May Contribute to the Pathophysiological Function of Mutant Leucine-Rich Repeat Kinase 2","volume":"62","author":"Caesar","year":"2014","journal-title":"Glia"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/ene.12090","article-title":"Reduced Serum Progranulin Level Might Be Associated with Parkinson\u2019s Disease Risk","volume":"20","author":"Mateo","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"fcab095","DOI":"10.1093\/braincomms\/fcab095","article-title":"Evidence for GRN Connecting Multiple Neurodegenerative Diseases","volume":"3","author":"Nalls","year":"2021","journal-title":"Brain Commun."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fimmu.2020.00033","article-title":"Molecular Signatures of Neuroinflammation Induced by \u03b1 Synuclein Aggregates in Microglial","volume":"11","author":"Kanthasamy","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Van Kampen, J.M., Baranowski, D., and Kay, D.G. (2014). Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson\u2019s Disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0097032"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"134873","DOI":"10.1016\/j.neulet.2020.134873","article-title":"Reduced Plasma Progranulin Levels Are Associated with the Severity of Parkinson\u2019s Disease","volume":"725","author":"Yao","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Sanchez-Mirasierra, I., Ghimire, S., Hernandez-Diaz, S., and Soukup, S.F. (2022). Targeting Macroautophagy as a Therapeutic Opportunity to Treat Parkinson\u2019s Disease. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.921314"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/22\/4431\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:36:12Z","timestamp":1763469372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/22\/4431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,16]]},"references-count":115,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["molecules30224431"],"URL":"https:\/\/doi.org\/10.3390\/molecules30224431","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,16]]}}}